Although sera shedding of IGFBP-3 increased slightly in the progression from primary to metastatic melanoma, the majority of IGFBP-3 sera levels in the melanoma patient cohort fell within the expected range for healthy adults (1.5–5.6 ug/ml). Here, IGFBP3 is linked to metastatic melanoma.